Posted in | News | Business | Chemistry

GAIL Chooses Shaw to Provide Technology and Engineering for Ethylene Facility in India

The Shaw Group Inc. (NYSE: SHAW) today announced it has been selected by GAIL (India) Limited (GAIL) to provide its proprietary technology and basic engineering for a new 450,000 tons per annum ethylene plant.

Shaw also will provide support during detailed engineering, procurement and construction, and commissioning and startup of the plant, which will be part of GAIL’s petrochemical complex in Pata, Uttar Pradesh, India.

“Shaw provided technology and basic engineering for GAIL’s first 400,000 tons per annum ethylene plant at Pata in the late 1990s. The performance of that plant, coupled with our ability to integrate it with the new parallel plant, will result in capital and energy savings for our customer,” said Lou Pucher, president of Shaw’s Energy & Chemicals Group.

The undisclosed value of the contract was included in Shaw's Energy & Chemicals segment's backlog of unfilled orders in the first quarter of fiscal year 2011.

Shaw has designed and/or built more than 120 grassroots ethylene plants worldwide. Five of those plants are in India, where Shaw also has participated in numerous projects to revamp or expand existing facilities. Shaw recently announced full commercial operation of a 1.3 million metric ton per year ethylene plant for Eastern Petrochemical Company (SHARQ) in Al-Jubail, Saudi Arabia.

The Shaw Group Inc. (NYSE:SHAW) is a leading global provider of engineering, construction, technology, fabrication, remediation and support services for clients in the energy, chemicals, environmental, infrastructure and emergency response industries. A Fortune 500 company with fiscal year 2010 annual revenues of $7 billion, Shaw has approximately 27,000 employees around the world and is the power sector industry leader according to Engineering News-Record’s list of Top 500 Design Firms.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.